CRNX
Crinetics Pharmaceuticals Inc
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+30/100
Last price
84.95
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
84.95
Day high
85.01
Day low
84.92
Volume
8.18M
Market cap
$9.01B
P/E (TTM)
—
52W range
32.30 – 85.01
Free account
3 more panels on CRNX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+956.83K
Net buying
Buy transactions
11
1.11M shares
Sell transactions
9
152.28K shares
Net transactions
+20
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
1.20M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 20, 26 | SCHILKE TOBIN Chief Financial Officer |
STOCK | 471 | $0 | Direct |
| Aug 7, 26 | STRUTHERS RICHARD SCOTT Chief Executive Officer |
CONVERSION | 19.93K | $399.99K | Direct |
| Jul 2, 26 | VIVALDI COELHO ROGERIO Director |
SELL | 3.00K | $120.00K | Direct |
| Jun 18, 26 | WIERENGA WENDELL Director |
STOCK | 5.92K | $0 | Direct |
| Jun 18, 26 | BEDROSIAN CAMILLE L Director |
STOCK | 5.92K | $0 | Direct |
| Jun 18, 26 | VIVALDI COELHO ROGERIO Director |
STOCK | 5.92K | $0 | Direct |
| Jun 18, 26 | OKEY STEPHANIE S Director |
STOCK | 5.92K | $0 | Direct |
| Jun 18, 26 | NICHOLS WESTON A Director |
STOCK | 5.92K | $0 | Direct |
| Jun 18, 26 | FUST MATTHEW K. Director |
STOCK | 5.92K | $0 | Direct |
| Jun 18, 26 | DEARDORF CAREN Director |
STOCK | 5.92K | $0 | Direct |
| Jun 17, 26 | OKEY STEPHANIE S Director |
SELL | 6.90K | $246.14K | Direct |
| May 29, 26 | STRUTHERS RICHARD SCOTT Chief Executive Officer |
STOCK | 968.80K | $0 | |
| Apr 8, 26 | KNIGHT JEFF E Chief Operating Officer |
SELL | 85.16K | $3.42M | Direct |
| Apr 8, 26 | KNIGHT JEFF E Chief Operating Officer |
CONVERSION | 78.43K | $1.76M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BETZ STEPHEN F |
Officer | 137.10K | Sale |
FUST MATTHEW K. |
Director | 28.76K | Stock Award(Grant) |
KALOFONOS ISABEL |
Officer | 34.83K | Stock Award(Grant) |
KNIGHT JEFF E |
Chief Operating Officer | 105.29K | Sale |
NICHOLS WESTON A |
Director | 22.23K | Stock Award(Grant) |
PIZZUTI DANA J |
Officer | 66.84K | Sale |
SCHILKE TOBIN |
Chief Financial Officer | 79.43K | Stock Award(Grant) |
STRUTHERS RICHARD SCOTT |
Chief Executive Officer | 1.40M | Conversion of Exercise of derivative security |
WIERENGA WENDELL |
Director | 122.07K | Stock Award(Grant) |
WILSON MARC |
Chief Financial Officer | 111.09K | Sale |
Fundamentals
Market cap$9.01B
Enterprise value$7.85B
Revenue (TTM)$42.16M
Gross profit$-334.72M
EBITDA$-544.85M
Net income$-501.61M
EPS (TTM)$-5.05
Free cash flow$-248.76M
Total cash$1.21B
Total debt$47.19M
Book value / share$11.27
Shares outstanding106.10M
Float95.50M
Short % of float7.26%
Dividend yield—
Beta (5Y)0.09
Valuation & profitability ratios
Trailing P/E—
Forward P/E-20.63
PEG ratio—
Price / sales—
Price / book7.54
EV / revenue186.25
EV / EBITDA-14.41
Gross margin0.00%
Operating margin-527.35%
Profit margin0.00%
Return on equity-42.45%
Return on assets-26.28%
Debt / equity3.96
Current ratio15.57
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $7.70M | $1.04M | $4.01M | $4.74M | +640.7% |
| Operating revenue | $7.70M | $1.04M | $4.01M | $4.74M | +640.7% |
| Cost of revenue | $1.08M | $0 | $0 | — | — |
| Gross profit | $6.62M | $1.04M | $4.01M | — | +537.2% |
| Research & development | $332.06M | $240.16M | $168.53M | $130.22M | +38.3% |
| Selling, general & admin | $191.33M | $99.74M | $58.09M | $42.39M | +91.8% |
| Total operating expense | $523.39M | $339.89M | $226.62M | $172.62M | +54.0% |
| Operating income | -$516.77M | -$338.85M | -$222.61M | -$167.88M | -52.5% |
| Net interest income | $51.99M | $41.44M | $13.44M | $4.32M | +25.5% |
| Pre-tax income | -$465.14M | -$298.41M | -$214.53M | -$163.92M | -55.9% |
| Tax provision | $180.00K | $0 | $0 | — | — |
| Net income | -$465.32M | -$298.41M | -$214.53M | -$163.92M | -55.9% |
| Net income to common | -$465.32M | -$298.41M | -$214.53M | -$163.92M | -55.9% |
| Basic EPS | -4.95 | -3.69 | -3.69 | -3.15 | -34.1% |
| Diluted EPS | -4.95 | -3.69 | -3.69 | -3.15 | -34.1% |
| EBIT | -$516.77M | -$338.85M | -$222.61M | -$167.88M | -52.5% |
| EBITDA | -$512.88M | -$336.07M | -$221.51M | -$166.90M | -52.6% |
| Basic shares | 94.06M | 80.78M | 58.07M | 51.98M | +16.4% |
| Diluted shares | 94.06M | 80.78M | 58.07M | 51.98M | +16.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $101.54M | $264.55M | $54.90M | $32.67M | -61.6% |
| Cash & short-term investments | $1.03B | $1.35B | $558.55M | $334.43M | -24.1% |
| Accounts receivable | $592.00K | $0 | — | — | — |
| Inventory | $2.02M | $0 | — | — | — |
| Total current assets | $1.05B | $1.38B | $574.15M | $345.18M | -23.8% |
| Property, plant & equipment | $54.79M | $55.58M | $57.43M | $4.99M | -1.4% |
| Total assets | $1.13B | $1.43B | $635.35M | $352.18M | -21.5% |
| Total current liabilities | $85.07M | $59.68M | $43.94M | $27.72M | +42.5% |
| Total debt | $48.54M | $51.72M | $51.73M | $3.08M | -6.2% |
| Total liabilities | $134.17M | $109.79M | $96.25M | $35.85M | +22.2% |
| Retained earnings | -$1.42B | -$952.11M | -$653.70M | -$439.17M | -48.9% |
| Shareholder equity | $992.08M | $1.32B | $539.11M | $316.33M | -25.1% |
| Working capital | $963.27M | $1.32B | $530.21M | $317.46M | -26.8% |
| Net tangible assets | $992.08M | $1.32B | $539.11M | $316.33M | -25.1% |
| Shares issued | 95.58M | 92.93M | 68.17M | 53.88M | +2.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$465.32M | -$298.41M | -$214.53M | -$163.92M | — | -55.9% |
| Depreciation & amortisation | $3.89M | $2.79M | $1.10M | $983.00K | — | +39.7% |
| Stock-based compensation | $91.02M | $69.39M | $40.94M | $28.27M | — | +31.2% |
| Change in working capital | $4.84M | $7.41M | $5.75M | $18.61M | — | -34.7% |
| Operating cash flow | -$377.92M | -$230.19M | -$168.60M | -$115.20M | — | -64.2% |
| Capital expenditure | -$5.76M | -$3.84M | -$4.69M | -$1.66M | — | -49.9% |
| Investing cash flow | $173.91M | -$574.82M | -$200.41M | -$173.98M | — | +130.3% |
| Share buybacks | $0 | -$14.98M | -$541.00K | — | $0 | +100.0% |
| Financing cash flow | $40.61M | $1.01B | $391.24M | $121.96M | — | -96.0% |
| Free cash flow | -$383.68M | -$234.04M | -$173.29M | -$116.86M | — | -63.9% |
| End cash position | $102.34M | $265.85M | $56.20M | $33.97M | — | -61.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $25.12M | $10.73M | $6.16M | $143.00K | $1.03M | — | +134.0% |
| Operating revenue | $25.12M | $10.73M | $6.16M | $143.00K | $1.03M | — | +134.0% |
| Cost of revenue | $154.00K | $200.00K | — | — | $0 | $0 | -23.0% |
| Gross profit | $24.96M | $10.53M | — | — | $1.03M | $361.00K | +137.0% |
| Research & development | $99.85M | $100.08M | $85.05M | $90.46M | $80.30M | — | -0.2% |
| Selling, general & admin | $57.57M | $50.83M | $53.70M | $52.27M | $49.84M | — | +13.3% |
| Total operating expense | $157.42M | $150.91M | $138.75M | $142.73M | $130.14M | — | +4.3% |
| Operating income | -$132.46M | -$140.38M | -$133.67M | -$142.59M | -$129.11M | — | +5.6% |
| Net interest income | $12.03M | $12.66M | $11.16M | $12.54M | $13.46M | — | -5.0% |
| Pre-tax income | -$120.86M | -$127.84M | -$122.64M | -$130.09M | -$115.64M | — | +5.5% |
| Net income | -$120.86M | -$127.84M | -$122.81M | -$130.09M | -$115.64M | — | +5.5% |
| Net income to common | -$120.86M | -$127.84M | -$122.81M | -$130.09M | -$115.64M | — | +5.5% |
| Basic EPS | -1.14 | -1.23 | -1.29 | -1.38 | -1.23 | — | +7.3% |
| Diluted EPS | -1.14 | -1.23 | -1.29 | -1.38 | -1.23 | — | +7.3% |
| EBIT | -$132.46M | -$140.38M | -$133.67M | -$142.59M | -$129.11M | — | +5.6% |
| EBITDA | -$131.39M | -$139.22M | -$132.67M | -$141.57M | -$128.15M | — | +5.6% |
| Basic shares | 105.56M | 104.10M | 95.10M | 94.22M | 93.79M | — | +1.4% |
| Diluted shares | 105.56M | 104.10M | 95.10M | 94.22M | 93.79M | — | +1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $55.50M | $114.34M | $101.54M | $110.90M | $53.73M | -51.5% |
| Cash & short-term investments | $1.21B | $1.29B | $1.03B | $1.09B | $1.20B | -6.6% |
| Accounts receivable | $11.96M | $5.68M | $592.00K | — | — | +110.4% |
| Inventory | $3.49M | $3.06M | $2.02M | — | — | +13.8% |
| Total current assets | $1.24B | $1.32B | $1.05B | $1.12B | $1.22B | -5.9% |
| Property, plant & equipment | $52.18M | $53.29M | $54.79M | $55.52M | $56.57M | -2.1% |
| Total assets | $1.32B | $1.40B | $1.13B | $1.20B | $1.29B | -5.7% |
| Total current liabilities | $79.92M | $71.09M | $85.07M | $74.16M | $68.40M | +12.4% |
| Total debt | $47.19M | $47.85M | $48.54M | $49.14M | $49.94M | -1.4% |
| Total liabilities | $129.92M | $120.68M | $134.17M | $123.86M | $118.05M | +7.7% |
| Retained earnings | -$1.67B | -$1.55B | -$1.42B | -$1.29B | -$1.16B | -7.8% |
| Shareholder equity | $1.19B | $1.28B | $992.08M | $1.07B | $1.17B | -6.9% |
| Working capital | $1.16B | $1.25B | $963.27M | $1.05B | $1.15B | -6.9% |
| Net tangible assets | $1.19B | $1.28B | $992.08M | $1.07B | $1.17B | -6.9% |
| Shares issued | 105.77M | 105.31M | 95.58M | 94.55M | 94.13M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$120.86M | -$127.84M | -$122.81M | -$130.09M | -$115.64M | — | +5.5% |
| Depreciation & amortisation | $1.07M | $1.16M | $994.00K | $1.01M | $959.00K | — | -7.5% |
| Stock-based compensation | $24.88M | $29.68M | $21.72M | $22.70M | $26.12M | — | -16.2% |
| Change in working capital | $2.05M | -$26.20M | $9.27M | -$1.50M | $6.60M | — | +107.8% |
| Operating cash flow | -$94.19M | -$124.70M | -$92.90M | -$110.72M | -$85.85M | — | +24.5% |
| Capital expenditure | -$521.00K | -$820.00K | -$458.00K | -$863.00K | -$3.20M | — | +36.5% |
| Investing cash flow | $26.29M | -$252.36M | $57.11M | $164.81M | $37.95M | — | +110.4% |
| Share buybacks | — | -$578.00K | — | — | — | $0 | — |
| Financing cash flow | $8.93M | $389.88M | $26.04M | $3.08M | $7.05M | — | -97.7% |
| Free cash flow | -$94.71M | -$125.52M | -$93.36M | -$111.58M | -$89.05M | — | +24.5% |
| End cash position | $56.30M | $115.14M | $102.34M | $112.20M | $55.03M | — | -51.1% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -1.18 | -1.14 | +3.7% |
| Mar 2026 | -1.20 | -1.23 | -2.9% |
| Dec 2025 | -1.37 | -1.29 | +5.7% |
| Sep 2025 | -1.25 | -1.38 | -10.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -1.13 | 8 | $41.69M | +29,053.8% |
| Next quarter | -1.07 | 8 | $84.31M | +1,268.5% |
| Current year | -4.54 | 8 | $161.85M | +2,003.1% |
| Next year | -4.01 | 7 | $178.61M | +10.4% |
Analyst targets & ownership
Mean target$85.00
High target$85.00
Low target$85.00
Implied upside0.06%
Analyst count8
ConsensusHOLD
Strong buy / Buy0 / 1
Hold8
Sell / Strong sell0 / 0
Held by insiders1.13%
Held by institutions119.21%
Institutions holding386
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
0.09
5Y monthly, from filing
Short interest
Shares short
6.59M
Prior 6.21M
Change vs prior
+6.1%
Shorts adding
% of float
7.26%
Normal
% of shares out
6.21%
Against total outstanding
Days to cover
2.3
Liquid
Float
95.50M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 28, 26 | UBS | DOWNGRADE | Buy | Neutral |
| Jul 8, 26 | TD Cowen | DOWNGRADE | Buy | Hold |
| Jul 8, 26 | Evercore ISI Group | DOWNGRADE | Outperform | In-Line |
| Jul 7, 26 | Jones Trading | DOWNGRADE | Buy | Hold |
| Jul 7, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Jul 7, 26 | Oppenheimer | DOWNGRADE | Outperform | Perform |
| Jul 7, 26 | Cantor Fitzgerald | DOWNGRADE | Overweight | Neutral |
| Jul 7, 26 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Jul 7, 26 | Baird | MAINTAINED | Outperform | Outperform |
| Jul 2, 26 | UBS | INITIATED | — | Buy |
| Jun 15, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 11, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
SEC filings
Offering Registrations
S-8 POS · 2026-09-01
Corporate Changes & Voting Matters
8-K · 2026-08-28
Corporate Changes & Voting Matters
8-K · 2026-08-19
Corporate Changes & Voting Matters
8-K · 2026-08-14
Corporate Changes & Voting Matters
8-K · 2026-08-03
Proxy Statements
DEFM14A · 2026-07-31
Proxy Statements
PREM14A · 2026-07-21
Corporate Changes & Voting Matters
8-K · 2026-07-10
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.